We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 23 May 2023. The event will focus on Roche’s efforts to address environmental sustainability challenges and highlight initiatives across the entire organization and value chain. 15:30 – 17:00 CEST / 14:30 – 16:00 BST 9:30 – 11:00 am EDT / 6:30 – 8:00 am PDT The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:30 CEST on the day of the event. > click here Agenda Welcome Bruno Eschli, Head of Investor Relations Why does ESG matter? Alan Hippe, Chief Financial and Information Officer Environmental sustainability through operational and product innovation Carbon emissions and the future of energy Scott Hemphill, Global Expert in Environmental Sustainability Sustainable construction Georg Singewald, Head of Global Manufacturing Science, Technology and Engineering Product stewardship in Pharma and Diagnostics Ursina Kohler, Head of Product Stewardship Water and waste management, and site remediation efforts Richard Huerzeler, Chief Environment and Remediation Officer Environmental sustainability in our supply chain Marielle Beyer, Head of Global Procurement Q&A Access to virtual event (pre-registration required) Please pre-register for our webinar here*. Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com. A replay of the webcast will be available via > ir.roche.com *privacy notice Best regards,
Bruno Eschli Head of Investor Relations	Alina Levchuk Investor Relations Officer

 

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com	Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

 

get the latest news and updates to your inbox.